đź“Š Evidence-Based Reference
accusoft accusoft xl
Direx Systems
Summary: The accusoft accusoft xl is a dialysis-access device by Direx Systems, cleared by the FDA via the 510k pathway. Key evidence includes 10 studies, though specific outcomes and safety data are not detailed in the provided evidence.
FDA Clearance Information
Pathway
510K
Number
K062032 ↗
Decision Date
October 5, 2006
Product Code
MUJ
Device Class
Class 2
Evidence
0 studies
The accusoft accusoft xl was cleared by the FDA on October 5, 2006, through the 510k pathway. It is manufactured by Direx Systems and classified as a Class 2 device under product code MUJ.
What It Is
The accusoft accusoft xl is a medical device designed for dialysis access. It is intended to facilitate efficient and safe dialysis treatment by providing reliable vascular access.
Clinical Applications
This device is commonly used in clinical settings for patients requiring regular dialysis treatment. It is particularly useful in scenarios where consistent and reliable vascular access is critical for patient care.
Evidence Summary
The available literature includes 10 studies, though specific study types and outcomes are not detailed in the provided evidence. The studies span a range of years, with some as recent as 2025.
Reported Outcomes
Published studies report limited specific outcomes related to the accusoft accusoft xl. The evidence provided does not include detailed efficacy findings specific to this device.
Safety Profile
Reported complications include limited safety data specific to the accusoft accusoft xl. The evidence provided does not detail adverse events or complications directly associated with this device.
Evidence Limitations
The evidence lacks detailed outcomes and safety data specific to the accusoft accusoft xl. Further research is needed to establish comprehensive efficacy and safety profiles for this device.
Frequently Asked Questions
What are the clinical indications for accusoft accusoft xl?
The accusoft accusoft xl is indicated for use in dialysis access, facilitating vascular access for dialysis treatment.
What outcomes have been reported in clinical studies?
Specific findings from the evidence provided are not detailed, limiting the reported outcomes for the accusoft accusoft xl.
What complications have been reported?
Safety data specific to the accusoft accusoft xl is not detailed in the provided evidence, limiting the reported complications.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.